Calvin Blissett on X
@mirror_mystery $FICO $PDD $UBER $KNSL $BN $KSPI $CPRT $CSU.TO at low $2,000s because of anchoring bias. $FISV. I do not own many of these, just where I think there’s value based on research I have done.
X
Everything we have picked from this writer, newest first.
@mirror_mystery $FICO $PDD $UBER $KNSL $BN $KSPI $CPRT $CSU.TO at low $2,000s because of anchoring bias. $FISV. I do not own many of these, just where I think there’s value based on research I have done.
@Smartonecapital Uh not many spots but gun to my head fertile hunting ground in the bigger names could be: $FICO, $BLDR, $KNSL. $PDD, $KSPI, $UBER. I have not looked into all extensively, some yes.
Nobert Lou crushed it on $NVR in the late 90s, his writeups under Charlie479 on VIC are mandatory reading. You will be a better investor after reading this and gain valuable mental models to overlay on interesting real life examples. Norbert invested in Burlington Northern before Buffett. Joel Greenblatt gave him money. His investment in Brahma profiled here is legendary and similar to Buffett with Coke. I lastly loved his mental models on TGS Nopec https://t.co/OZorTJIv9W
I’m always fascinated by the huge value in large caps and how to frame it. Buffett in $AAPL, $KO, $WFC historically. Terry Smith $DPZ. Ackman $CMG, $CP. $GOOG like a year and a half ago. Mohnish Pabrai called out $META a few years ago and it multi bagged. This is a useful example $MSFT in 2006.
@RodAlzmann I did think $CASH was interesting, I have heard about $GDOT before, Rod I admire your work and think your a good analyst could you give the quick elevator pitch?
$BMBL looking past GAAP accounting like a 1x Owner's Earnings multiple, not shrinking fast, executing turnaround strategy and optimizing for quality over quantity. Founder back, paying off debt more than doubles the equity. Which the FCF says they can do. https://t.co/6byxo2vb8s
$JRVR ~4x multiple. Below adjusted book of circa $6.68 per share, activist, E&S is a good niche, mgmt rationalizing for economics. This one has messed up bad many times in the past and probably deservedly has a horrible reputation https://t.co/CD2VZ19KO0
$ARKO Trading below the value of it's stake in $APC, transferring to asset light business model, targeting 10% dividend https://t.co/kDZ2zPoIkm
$ADMA Profitable small cheap biotech with 3 FDA approvals accelerated stock repurchase plan https://t.co/jVbFVNKBA5